Septal Closure Device with Integrated Differential Pressure Sensing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing medical technologies lack effective methods for direct cardiac pressure monitoring, particularly in the left atrium, which is crucial for early detection of congestive heart failure, leading to unreliable symptom-based treatments and high hospital readmissions.

Innovation Solution

Implantable septal closure devices with integrated pressure sensors, such as those with occluding membranes and tissue anchors, allow for direct monitoring of cardiac pressures, including differential pressure between atria, enabling early detection of fluid buildup and guiding proactive medication adjustments.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If direct cardiac pressure monitoring is implemented, then measurement precision is improved, but device complexity increases

Engineering Contradiction:
Improvepressure monitoring accuracyVSAvoidimplant device structure
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent combines pressure sensing functionality with existing cardiac implant devices (occluders, spacers, repair devices) by integrating pressure sensor elements directly into these devices. This merging approach allows direct cardiac pressure monitoring to be implemented without adding separate monitoring devices, thereby improving measurement precision while minimizing the increase in overall device complexity.

Inventive Principle:
Principle #5Merging (Combining)

2Measurement precision

If pressure sensor device is attached to occluding membrane, then measurement precision is improved, but ease of manufacture deteriorates

Engineering Contradiction:
Improvepressure sensing accuracyVSAvoiddevice assembly process
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The pressure sensor device is pre-attached to the occluding membrane during the manufacturing process before final implantation. This preliminary action ensures that the sensor is correctly positioned and secured to the membrane, improving measurement precision while allowing the assembly to be completed in a controlled manufacturing environment, thereby mitigating the impact on ease of manufacture.

Inventive Principle:
Principle #10Preliminary action

3Measurement precision

If multiple pressure sensor elements are used, then measurement precision is improved, but device complexity increases

Engineering Contradiction:
Improvedifferential pressure measurementVSAvoidsensor device structure
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The pressure monitoring function is segmented into multiple sensor elements (first pressure sensor element on one side of the membrane, second pressure sensor element on the other side) that can be independently positioned and function. This segmentation enables differential pressure measurement across the membrane, improving measurement precision while allowing each sensor element to be relatively simple in structure, thereby managing overall device complexity.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Facilitates early detection of congestive heart failure, reducing hospital readmissions and morbidity by providing accurate pressure monitoring and enabling timely intervention.

Implementation Method 1

a pressure sensor device attached to the occluding membrane. The pressure sensor device comprises a first portion disposed on a first side of the occluding membrane and a second portion disposed on a second side of the occluding membrane

Methodology Applied
Scientific EffectPressure sensing:

Data Source

PatentUS12383202B2Direct cardiac pressure monitoring
Publication Date: 2025.08.12 EDWARDS LIFESCIENCES CORP
  • US12383202B2 patent drawing
  • US12383202B2 patent drawing
  • US12383202B2 patent drawing

AI summary

A septal closure device includes a frame comprising one or more tissue anchor features, an occluding membrane, and a pressure sensor device attached to the occluding membrane.